FREE SHIPPING ON ORDERS OVER $150

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

$29.31

Quantity
- +
Description

Mechanistically, EDCs can act as agonists or antagonists at estrogen receptors (ER and ER), androgen receptors (ARs), or thyroid hormone receptors (TRs), thereby altering receptor conformation, recruitment of coactivators or corepressors, and downstream transcriptional activity [72,73]

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

Le et al., 2021

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

10.1515/BC.2002.051

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

(1988) in Zuckerman, A

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

J.McCrackenK.CoxG

liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Frontiers | Ferroptosis in Parkinson's

You may also like

Dr

US$ 26.72

4.9 (14 reviews)

recommand products